Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan

被引：15
|
作者：
Saito, H. [1 ]
Tani, Y. [2 ]
Ozaki, A. [2 ,5 ]
Sawano, T. [3 ]
Shimada, Y. [4 ]
Yamamoto, K. [2 ]
Tanimoto, T. [2 ]
机构：
[1] Sendai Kousei Hosp, Dept Gastroenterol, Sendai, Miyagi, Japan
[2] Med Governance Res Inst, Minato Ku, Tokyo, Japan
[3] Minamisoma Municipal Gen Hosp, Dept Surg, Fukushima, Japan
[4] Minamisoma Municipal Gen Hosp, Dept Neurosurg, Fukushima, Japan
[5] Tokiwa Fdn, Jyoban Hosp, Dept Breast Surg, Iwaki, Fukushima, Japan
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2019年 / 25卷 / 11期
关键词：
Clinical practice guidelines; Financial conflicts of interest; Methicillin-resistant Staphylococcus aureus guidelines; Payments database; Transparency; INDUSTRY;
D O I：
10.1016/j.cmi.2019.07.025
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1304 / 1306
页数：3
相关论文
共 50 条
  • [41] Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (05) : 828 - 829
  • [42] USE OF CLINICAL PRACTICE GUIDELINES BY PHYSICIANS IN JAPAN
    Shimbo, T.
    Suzuki, T.
    Takahashi, O.
    Tanaka, Y.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A485 - A485
  • [43] Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
    Saito, Hiroaki
    Ozaki, Akihiko
    Sawano, Toyoaki
    Shimada, Yuki
    Tanimoto, Tetsuya
    [J]. JAMA NETWORK OPEN, 2019, 2 (04) : e192834
  • [44] Financial ties between DSM-IV panel members and the pharmaceutical industry
    Cosgrove, L
    Krimsky, S
    Vijayaraghavan, M
    Schneider, L
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2006, 75 (03) : 154 - 160
  • [45] Evaluation of Financial Conflicts of Interest Among Physician-Authors of American College of Rheumatology Clinical Practice Guidelines
    Wayant, Cole
    Walters, Corbin
    Zaaza, Zachary
    Gilstrap, Carrie
    Combs, Tyler
    Crow, Hanna
    Vassar, Matt
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (09) : 1427 - 1434
  • [46] Separating practice guidelines from pharmaceutical marketing
    Eichacker, Peter Q.
    Natanson, Charles
    Danner, Robert L.
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (12) : 2877 - 2878
  • [47] Payments from pharmaceutical companies to authors involved in the valsartan scandal in Japan (vol 2, e193817, 2019)
    Sawano, T.
    Ozaki, A.
    Saito, H.
    Shimada, Y.
    Tanimoto, T.
    [J]. JAMA NETWORK OPEN, 2019, 2 (07)
  • [48] Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020
    Murayama, Anju
    Saito, Hiroaki
    Tanimoto, Tetsuya
    Ozaki, Akihiko
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2023, 29 (06) : 883 - 886
  • [49] Representation of Authors by Gender, Race, and Ethnicity in Clinical Practice Guidelines
    Martin, Amarilis A.
    Walker, Shannon C.
    Wheeler, Allison P.
    Jacobs, Jeremy W.
    Booth, Garrett S.
    Silver, Julie K.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (02) : 230 - 241
  • [50] Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe
    Kudo, M.
    [J]. LIVER CANCER, 2015, 4 (02) : 85 - 95
12345